TBG Biotechnology (Xiamen) Inc., a subsidiary owned by Medigen Biotechnology, passed EN ISO 13485:2012 on October 09, 2015. The certification represents not only the full compliance with the requirements of ISO13485 but also a milestone for us to step forward into international in vitro diagnostic devices (IVD) production center.
![[新聞二附圖]TBG-SGS](http://before2025.medigen.com.tw/wp-content/uploads/2015/11/新聞二附圖TBG-SGS.jpg)